The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial
作者： S. M. Miller , S. V. Hudson , B. L. Egleston , S. Manne , J. S. Buzaglo
DOI: 10.1002/PON.3043
关键词:
摘要: Background Cancer clinical trials (CCTs) are important tools in the development of improved cancer therapies; yet, participation is low. Key psychosocial barriers exist that appear to impact a patient’s decision participate. Little known about relationship among knowledge, self efficacy, preparation, decisional conflict, and patient decisions take part CCTs.
sci-hub.se 参考文章(48)
CARRIE N. KLABUNDE, Bethesda, BRIAN C. SPRINGER, BELINDA BUTLER, Winston-Salem, MARION S. WHITE, Raleigh, JAMES ATKINS, Factors influencing enrollment in clinical trials for cancer treatment. Southern Medical Journal. ,vol. 92, pp. 1189- 1193 ,(1999) , 10.1097/00007611-199912000-00011
Sue Ross, Adrian Grant, Carl Counsell, William Gillespie, Ian Russell, Robin Prescott, Barriers to participation in randomised controlled trials: a systematic review. Journal of Clinical Epidemiology. ,vol. 52, pp. 1143- 1156 ,(1999) , 10.1016/S0895-4356(99)00141-9
Winn Rj, Obstacles to the accrual of patients to clinical trials in the community setting. Seminars in Oncology. ,vol. 21, pp. 112- 117 ,(1994)
Ronald S. Go, Kathleen A. Frisby, Jennifer A. Lee, Michelle A. Mathiason, Christine M. Meyer, Jodi L. Ostern, Sara M. Walther, Jonean E. Schroeder, Lori A. Meyer, Kathryn E. Umberger, Clinical trial accrual among new cancer patients at a community‐based cancer center Cancer. ,vol. 106, pp. 426- 433 ,(2006) , 10.1002/CNCR.21597
Jeremy Ho, Gregory R Pond, Colin Newman, Martha Maclean, Eric X Chen, Amit M Oza, Lillian L Siu, Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital BMC Cancer. ,vol. 6, pp. 263- 263 ,(2006) , 10.1186/1471-2407-6-263
Peter M. Ellis, Phyllis N. Butow, Martin H.N. Tattersall, Stewart M. Dunn, Nehmat Houssami, Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate Journal of Clinical Oncology. ,vol. 19, pp. 3554- 3561 ,(2001) , 10.1200/JCO.2001.19.15.3554
Beverly A. Weidmer, Meredith L. Kilgore, Nikhil Wagle, John L. Adams, Robert A. Figlin, Joy H. Lewis, Joel Cohen, Richard Kaplan, Mary McCabe, Dana P. Goldman, Michael L. Schoenbaum, Arnold L. Potosky, Jane C. Weeks, Sandra H. Berry, Jose J. Escarce, Measuring the Incremental Cost of Clinical Cancer Research Journal of Clinical Oncology. ,vol. 19, pp. 105- 110 ,(2001) , 10.1200/JCO.2001.19.1.105
Electra D. Paskett, M. Robert Cooper, Nancy Stark, Thomas C. Ricketts, Sara Tropman, Teresa Hatzell, Tim Aldrich, James Atkins, Clinical trial enrollment of rural patients with cancer. Cancer Practice. ,vol. 10, pp. 28- 35 ,(2002) , 10.1046/J.1523-5394.2002.101006.X
Reuben M. Baron, David A. Kenny, The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology. ,vol. 51, pp. 1173- 1182 ,(1986) , 10.1037/0022-3514.51.6.1173
James R. Wright, Dauna Crooks, Peter M. Ellis, Deborah Mings, Tim J. Whelan, Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate. Cancer. ,vol. 95, pp. 1584- 1591 ,(2002) , 10.1002/CNCR.10864